A randomized clinical trial with natural interferon-α monotherapy for 24 or 48 weeks on patients with chronic hepatitis C having genotype 1b infection in high viral titers

スポンサーリンク

概要

論文の詳細を見る
2002-12-01

著者

関連論文

Spatial and chronological differences in hepatitis B virus genotypes from patients with acute hepatitis B in Japan
Timing of interferon therapy and sources of infection in patients with acute hepatitis C
Reactivation of hepatitis B virus in HBsAg-negative patients with multiple myeloma : two case reports
Impact of daily high-dose IFNα-2b plus ribavirin combination therapy on reduction of ALT levels in patients with chronic hepatitis C with genotype 1 and high HCV RNA levels
Prediction of treatment outcome with daily high-dose IFN α-2b plus ribavirin in patients with chronic hepatitis C with genotype 1b and high HCV RNA levels : relationship of baseline viral levels and viral dynamics during and after therapy
A significant reduction in serum alanine aminotransferase levels after 3-month iron reduction therapy for chronic hepatitis C : a multicenter, prospective, randomized, controlled trial in Japan
Pregnancy-Associated Cytotoxic Lymphoma: A Report of 4 Cases
Detection of API2-MALT1 Fusion Transcripts in Cytologic Specimens of Patients with Pulmonary Mucosa-Associated Lymphoid Tissue Lymphoma
MUM1/IRF4 Expression Is an Unfavorable Prognostic Factor in B-Cell Chronic Lymphocytic Leukemia(CLL)/Small Lymphocytic Lymphoma(SLL)
Lineage Conversion from Acute Lymphoblastic Leukemia to Acute Myeloid Leukemia on Rearrangement of the IgH Gene in a Patient with Down Syndrome
A randomized, double-blind, controlled trial of natural interferon-β therapy for e-antigen-negative chronic hepatitis B patients with abnormal transaminase levels
A case of complete necrosis of well-differentiated early hepatocellular carcinoma by percutaneous transhepatic portal embolization
Serum HCV RNA levels during early phase of recombinant interferon alfa-2a (Roferon A) therapy for chronic hepatitis C and efficacy of short-term therapy with earlier loss of viremia
Short-term prolongation of pegylated interferon and ribavirin therapy for genotype 1b chronic hepatitis C patients with early viral response
Assessment of hepatic steatosis and hepatic tissue blood flow by xenon computed tomography in nonalcoholic steatohepatitis
Effect of treatment with interferon α-2b and ribavirin in patients infected with genotype 2 hepatitis C virus
Amino acid substitutions in the S region of hepatitis B virus in sera from patients with acute hepatitis
A case of deep venous thrombosis associated with pegylated interferon α2b plus ribavirin treatment of chronic hepatitis C
Detection, using a novel method, of a high prevalence of cryoglobulinemia in persistent hepatitis C virus infection
Serum lipid profile of patients with genotype 1b hepatitis C viral infection in Japan
One-point quantitative determination of pretreatment serum hepatitis C virus RNA predicts long-term responsiveness to high-dose interferon therapy
Intrahepatic hepatitis C virus RNA levels after interferon treatment: eradication of the minus-strand RNA correlates with sustained remission of hepatitis
Bortezomib-induced apoptosis in mature T-cell lymphoma cells partially depends on upregulation of Noxa and functional repression of Mcl-1
Overexpression of carboxylesterase-2 results in enhanced efficacy of topoisomerase I inhibitor, irinotecan (CPT-11), for multiple myeloma
Frequent occurrence of CCND1 deregulation in patients with early stages of plasma cell dyscrasia
Therapeutic effects of stronger neo-minophagen C at different doses on chronic hepatitis and liver cirrhosis
Efficacy of interferon alfacon-1 daily induction therapy followed by three-times weekly therapy in patients with chronic hepatitis C virus infection with high and low viral titers
Involvement of GBV-C/HGV in liver diseases in Japan
T-Cell Acute Lymphoblastic Leukemia as a Secondary Leukemia after a 3-Year Remission of Acute Myelocytic Leukemia
Lack of Ku80 Alteration in Multiple Myeloma
Successful Treatment of Nasal T-Cell Lymphoma With a Combination of Local Irradiation and High-Dose Chemotherapy
Superior Mesenteric Venous Thrombosis Associated With a Familial Missense Mutation (Pro626Leu) in the SHBG-Like Domain of the Protein S Molecule
Sustained activation of c-jun-N-terminal kinase plays a critical role in arsenic trioxide-induced cell apoptosis in multiple myeloma cell lines
Mutations in the non-structural protein 5A gene in patients with chronic hepatitis C virus 1b infection during repeated interferon treatment
Amino acid mutations in the interferon sensitivity determining region and serum virus load in hepatitis C virus carriers with long-term normal ALT levels
A randomized clinical trial with natural interferon-α monotherapy for 24 or 48 weeks on patients with chronic hepatitis C having genotype 1b infection in high viral titers
New Inuyama classification; new criteria for histological assessment of chronic hepatitis^1
Different hepatitis B virus genotype distributions among asymptomatic carriers and patients with liver diseases in Nanning, southern China
Congenital Hepatic Fibrosis with Fatal Cholestatic Liver Damage
Serum type IV collagen in various liver diseases in comparison with serum 7S collagen, laminin, and type III procollagen peptide
A multicenter, randomized, controlled clinical trial of interferon alfacon-1 in comparison with lymphoblastoid interferon-alpha in patients with high-titer chronic hepatitis C virus infection
Risk of Japanese carriers of hyperphosphorylated paratarg-7, the first autosomal-dominantly inherited risk factor for hematological neoplasms, to develop monoclonal gammopathy of undetermined significance and multiple myeloma

もっと見る

スポンサーリンク